Our proprietary OneBac platform uses a baculovirus expression system to infect cells derived from the Spodoptera frugiperda larval moth. Using a chemically defined medium, our system provides a platform to deliver superior yields and purification of infectious AAV for use in gene therapy applications. These key advantages are accompanied by a reduction in the requirement for manufacturing components, providing a cost-effective system to develop the highest quality material for patients.